Self-reported drug use and mortality among a nationwide sample of Swedish conscripts - A 35-year follow-up

Drug and Alcohol Dependence

Volumn 118, Issue 2-3, 2011, Pages 383-390

  Davstad, Ingrid ^a,b   Allebeck, Peter ^a   Leifman, Anders ^a,b   Stenbacka, Marlene ^a,b   Romelsjö, Anders ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Drug use; Epidemiology; Inpatient care; Longitudinal study; Mortality; Risk factors

Indexed keywords

CANNABIS; CENTRAL STIMULANT AGENT; HYPNOTIC AGENT; ILLICIT DRUG; OPIATE DERIVATIVE; PSYCHEDELIC AGENT; SEDATIVE AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DRUG USE; ETHNIC GROUP; FOLLOW UP; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PATIENT CARE; PRIORITY JOURNAL; REGISTER; RISK FACTOR; SELF REPORT; SUICIDE; SWEDISH;

CAUSE OF DEATH; DRUG USERS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MORTALITY, PREMATURE; PREVALENCE; SELF REPORT; SUBSTANCE-RELATED DISORDERS; SWEDEN;

CANNABIS;

EID: 80053575241     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.04.025     Document Type: Article

References (59)

1. Adamsson Wahren C., Brandt L., Allebeck P. Has mortality in drug addicts increased? A comparison between two hospitalized cohorts in Stockholm. Int. J. Epidemiol. 1997, 26:1219-1226.
2. Agrell J. Missbruk av narkotika, thinner och läkemedel bland inskrivningsskyldiga 1967-1970/71 (Use of narcotics, solvents and drugs among conscripts 1967-1970/71.) A-rapport nr 15, april 1972 1972, Militärpsykologiska institutet (MPI), Stockholm.
3. Allebeck P., Allgulander C., Fisher L.D. Predictors of completed suicide in a cohort of 50465 young men: role of personality and deviant behaviour. BMJ 1988, 297:176-178.
4. Andréasson S., Allebeck P., Romelsjö A. Alcohol and mortality among young men: longitudinal study of Swedish conscripts. BMJ 1988, 296:1021-1025.
5. Andréasson S., Allebeck P. Cannabis and mortality among young men: a longitudinal study of Swedish conscripts. Scand. J. Soc. Med. 1990, 18:9-15.
6. Andréasson S., Romelsjö A., Allebeck P. Alcohol, social factors and mortality among young men. Br. J. Addict. 1991, 86:877-887.
7. Bargagli A.M., Sperati A., Davoli M., Forastiere F., Perucci C.A. Mortality among problem drug users in Rome: an 18-year follow-up study, 1980-97. Addiction 2001, 96:1455-1463.
8. Bartu A., Freeman N.C., Gawthorne G.S., Codde J.P., Holman C.D.A.J. Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia. Addiction 2004, 99:53-60.
9. Batty G.D., Modig Wennerstad K., Davey Smith G., Gunnell D., Deary I.J., Tynelius P., Rasmussen F. IQ in early adulthood and mortality by middle age. Epidemiology 2009, 20:100-109.
10. Benson G., Holmberg M.B. Validity of questionnaires in population studies on drug use. Acta Psychiatr. Scand. 1985, 71:9-18.
11. Bird S.M., Hutchinson S.J., Goldberg D.J. Drug-related deaths by region, sex and age group per 100 injecting drug users in Scotland, 2000-01. Lancet 2003, 362:941-944.
12. Bjornaas M.A., Bekken A.S., Ojlert A., Haldorsen T., Jacobsen D., Rostrup M., Ekeberg O. A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo. BMC Psychiatry 2008, 8:8. doi:1186/1471-244X-8-8.
13. Bykvist, S. 1997. Svenska narkotikamissbrukande kvinnor och män, missbruksförlopp och kriminalitet (Swedish men and women using narcotics, progression of drug use and criminality). Thesis. Stockholm University, Department of Social Work, School of Social Work, Stockholm, p. 299.
14. Calabria B., Degenhardt L., Hall W., Lynskey M. Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev. 2010, 29:318-330.
15. Carlstedt B. Cognitive abilities - aspects of structure, process and measurement Göteborg studies in educational sciences 148. Acta Universitatis Gothoburgensis. Göteborg 2000.
16. Centralförbundet för alkohol- och narkotikaupplysning (Federation of alcohol- and drug awareness), 2007. Rapport nr 107. Drogutvecklingen i Sverige 2007 (Report No. 107. Drogutvecklingen i Sverige 2007 Drug development in Sweden in 2007), Stockholm.p. 25. (accessed 03.23.11). http://www.can.se/documents/CAN/Rapporter/rapportserie/CAN_RS_107.pdf.
17. Centralförbundet för alkohol- och narkotikaupplysning (Swedish Council for Information on Alcohol and Other Drugs), 2010. Rapport nr 125. Drogutvecklingen i Sverige 2010 (Report No. 125. Drogutvecklingen i Sverige 2007 Drug development in Sweden in 2010), Stockholm. p. 104 (accessed 03.23.11). http://www.can.se/documents/CAN/Rapporter/rapportserie/can-rapportserie-125-drogutvecklingen-i-sverige-2010.pdf.
18. Chen K., Kandel D.B. The natural history of drug use from adolescence to the mid-thirties in a general population sample. Am. J. Public Health 1995, 85:41-47.
19. Copeland L., Budd J., Robertson J.R., Elton R.A. Changing patterns in causes of death in a cohort of injecting drug-users 1980-2001. Arch. Intern. Med. 2004, 164:1214-1220.
20. Darke S., Degenhardt L., Mattick R. Mortality Amongst Illicit Drug Users: Epidemiology, Causes and Intervention 2007, Cambridge University Press, Cambridge.
21. David A.S., Malmberg A., Brandt L., Allebeck P., Lewis G. IQ and risk for schizophrenia: a population-based cohort study. Psychol. Med. 1997, 27:1311-1323.
22. Degenhardt L., Coffey C., Carlin J.B., Swift W., Moore E., Patton G.C. Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia. Br. J. Psychiatry 2010, 196:290-295.
23. Degenhardt L., Hall W., Lynskey M. The relationship between cannabis use and other substance use in the general population. Drug Alcohol Depend. 2001, 64:319-327.
24. Engström A., Adamsson C., Allebeck P., Rydberg U. Mortality in patients with substance use - a follow-up in Stockholm county 1973-84. Int. J. Addict. 1991, 26:91-106.
25. European Monitoring Centre for Drugs and Drug Addiction Annual Report 2010. The State of the Drugs Problem in Europe. Publications Office of the European Union. Luxembourg. Commentary: The Current Landscape for European Drug Policy 2010, p. 15. http://www.emcdda.europa.eu/attachements.cfm/att_120104_EN_EMCDDA_AR2010_EN.pdf (accessed 03.23.11).
26. European Monitoring Centre for Drugs and Drug Addiction Annual Report 2010. The State of the Drugs Problem in Europe. Publications Office of the European Union. Luxembourg. Chapter 1: Policies and Laws 2010, p. 23. http://www.emcdda.europa.eu/attachements.cfm/att_120104_EN_EMCDDA_AR2010_EN.pdf (accessed 03.23.11).
27. Fergusson D.M., Boden J.M., Horwood L.J. The developmental antecedents of illicit drug use: evidence from a 25-year longitudinal study. Drug Alcohol Depend. 2008, 96:165-177.
28. Fergusson D.M., Horwood L.J. Does cannabis use encourage other forms of illicit drug use?. Addiction 2000, 95:505-520.
29. Frej G. Case-finding survey angående narkotikamissbrukare kända av olika myndigheter i Stor-Stockholm under tiden 1 juli-31 december 1967 (Case finding survey concerning drug users known by authorities in Stockholm area July 1-December 31 1967). Commission of Inquiry on Care of Drug Addicts. The Narcotic Problem. The Swedish Government Official Reports (SOU 1969 53) 1969, The Ministry of Health and Social Affairs, Stockholm, p. 204.
30. Fugelstad A., Annell A., Rajs J., Ågren G. Mortality, and causes and manners of death among drug addicts in Stockholm 1985-1992. Acta Psychiatr. Scand. 1997, 96:169-175.
31. Fugelstad A., Stenbacka M., Leifman A., Nylander M., Thiblin I. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. Addiction 2007, 102:406-412.
32. Fuller C.M., Vlahov D., Arria A.M., Ompad D.C., Garfein R., Strathdee S.A. Factors associated with adolescent initiation of injection drug use. Public Health Rep. 2001, 116(Suppl. 1):136-145.
33. Galobardes B., Lynch J.W., Davey Smith G. Is the association between childhood socioeconomic circumstances and cause-specific mortality established? Update of a systematic review. J. Epidemiol. Community Health 2008, 62:387-390.
34. Ghodse H., Oyefeso A., Kilpatrick B. Mortality of drug addicts in the United Kingdom 1967-1993. Int. J. Epidemiol. 1998, 27:473-478.
35. Gossop M., Stewart D., Treacy S., Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction 2002, 97:39-47.
36. Hser Y.I., Hoffman V., Grella C.E., Anglin D. A 33-year follow-up of narcotics addicts. Arch. Gen. Psychiatry 2001, 58:503-508.
37. Korhonen T., Huizink A.C., Dick D.M., Pulkkinen L., Rose R.J., Kaprio J. Role of individual, peer and family factors in the use of cannabis and other illicit drugs: a longitudinal analysis among Finnish adolescent twins. Drug Alcohol Depend. 2008, 97:33-43.
38. McCarron P., Davey Smith G., Okasha M., McEwen J. Smoking in adolescence and young adulthood and mortality in later life: prospective observational study. J. Epidemiol. Community Health 2001, 55:334-335.
39. Neeleman J., Wessely S., Wadsworth M. Predictors of suicide, accidental death, and premature natural death in a general-population birth cohort. Lancet 1998, 351:93-97.
40. Otto U. Function of male youths during military service A follow-up study of a youth clientele. Acta Psychiatr. Scand. Suppl. 1980, 282(61).
41. Perkonigg A., Goodwin R.D., Fiedler A., Behrendt S., Beesdo K., Lieb R., Wittchen H.-U. The natural course of cannabis use, abuse and dependence during the first decades of life. Addiction 2008, 103:439-449.
42. Price C., Hemmingsson T., Lewis G., Zammit S., Allebeck P. Cannabis and suicide: longitudinal study. Br. J. Psychiatry 2009, 195:492-497.
43. Romelsjö A., Kaplan G.A., Cohen R.D., Allebeck P., Andréasson S. Protective factors and social risk factors for hospitalisation and mortality among young men. Am. J. Epidemiol. 1992, 135:649-658.
44. Rossow I. Suicide among drug addicts in Norway. Addiction 1994, 89:1667-1673.
45. Sinha R. Chronic stress, drug use and vulnerability to addiction. Ann. N. Y. Acad. Sci. 2008, 1141:105-130.
46. Stattin H., Romelsjö A. Adult mortality in the light of criminality, substance abuse, and behavioural and family risk factors in adolescence. Crim. Behav. Ment. Health 1995, 5:279-311.
47. Stenbacka M. Problematic alcohol and cannabis use in adolescence-risk of serious adult substance use?. Drug Alcohol Rev. 2003, 22:277-286.
48. Stenbacka M. The role of competence factors in reducing the future risk of drug use among young Swedish men. Addiction 2000, 95:1573-1581.
49. Stenbacka M., Allebeck P., Romelsjö A. Intravenous drug use in young men: risk factors assessed in a longitudinal perspective. Scand. J. Soc. Med. 1992, 20:94-101.
50. Stenbacka M., Allebeck P., Romelsjö A. Do cannabis drug abusers differ from intravenous drug abusers? The role of social and behaviourial risk factors. Br. J. Addict. 1992, 87:259-266.
51. Tunving K. Fatal outcome in drug addiction. Acta Psychiatr. Scand. 1988, 77:551-566.
52. United Nations Office on Drugs and Crime (UNODC) World Drug Report 2010. Illicit Drug Use at the Global Level 2008 2010, p. 13. United Nations Publication Sales No. E.10.XI.13. http://www.unodc.org/documents/wdr/WDR_2010/World_Drug_Report_2010_lo-res.pdf (accessed 12.21.10).
53. Upmark M., Lundberg I., Sadigh J., Allebeck P., Bigert C. Psychosocial characteristics in young men as predictors of early disability pension with a psychiatric diagnosis. Soc. Psychiatry Psychiatr. Epidemiol. 1999, 34:533-540.
54. van Haastrecht H.J.A., van Ameijden E.J.C., van den Hoek J.A.R., Mientjes G.H.C., Bax J.S., Coutinho R.A. Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users. Am. J. Epidemiol. 1996, 143:380-391.
55. White A., Holmes M. Patterns of mortality across 44 countries among men and women aged 15-44 years. J. Mens Health Gend. 2006, 3:139-151.
56. World Health Organization (WHO) Global Health Risks. Addictive Substances 2009, WHO Press, Geneva, Switzerland, p. 22. http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf (accessed 15.11.10).
57. World Health Organisation (WHO) International Statistical Classification of Diseases and Related Health Problems. Eight Revision (ICD-8) 1967, WHO.
58. World Health Organisation (WHO) International Statistical Classification of Diseases and Related Health Problems. Ninth Revision (ICD-9) 1978, WHO.
59. World Health Organisation (WHO) International Statistical Classification of Diseases and Related Health Problems. Tenth Revision (ICD-10) 1992, WHO.